Craig M. Bula, Ph.D.
Affiliations: | 2003 | University of California, Riverside, Riverside, CA, United States |
Area:
BiochemistryGoogle:
"Craig Bula"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Anthony W. Norman | grad student | 2003 | UC Riverside | |
| (Molecular mechanisms for transcriptional activation by the vitamin D nuclear receptor: Selective mutagenesis to define ligand hydrogen-bond specificity, conformational stability and antagonism.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mizwicki MT, Bula CM, Mahinthichaichan P, et al. (2009) On the mechanism underlying (23S)-25-dehydro-1alpha(OH)-vitamin D3-26,23-lactone antagonism of hVDRwt gene activation and its switch to a superagonist. The Journal of Biological Chemistry. 284: 36292-301 |
| Deng C, Ueda E, Chen KE, et al. (2009) Prolactin blocks nuclear translocation of VDR by regulating its interaction with BRCA1 in osteosarcoma cells. Molecular Endocrinology (Baltimore, Md.). 23: 226-36 |
| Bula CM, Bishop JE, Norman AW. (2007) Conservative mutageneic perturbations of amino acids connecting helix 12 in the 1alpha,25(OH)2-D3 receptor (VDR) to the ligand cause significant transactivational effects. The Journal of Steroid Biochemistry and Molecular Biology. 103: 286-92 |
| Mizwicki MT, Bula CM, Bishop JE, et al. (2007) New insights into Vitamin D sterol-VDR proteolysis, allostery, structure-function from the perspective of a conformational ensemble model. The Journal of Steroid Biochemistry and Molecular Biology. 103: 243-62 |
| Bula CM, Huhtakangas J, Olivera C, et al. (2005) Presence of a truncated form of the vitamin D receptor (VDR) in a strain of VDR-knockout mice. Endocrinology. 146: 5581-6 |
| Mizwicki MT, Bula CM, Bishop JE, et al. (2005) A perspective on how the Vitamin D sterol/Vitamin D receptor (VDR) conformational ensemble model can potentially be used to understand the structure-function results of A-ring modified Vitamin D sterols. The Journal of Steroid Biochemistry and Molecular Biology. 97: 69-82 |
| Collins ED, Bishop JE, Bula CM, et al. (2005) Effect of 25-hydroxyl group orientation on biological activity and binding to the 1alpha,25-dihydroxy vitamin D3 receptor. The Journal of Steroid Biochemistry and Molecular Biology. 94: 279-88 |
| Vertino AM, Bula CM, Chen JR, et al. (2005) Nongenotropic, anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases. The Journal of Biological Chemistry. 280: 14130-7 |
| Mizwicki MT, Keidel D, Bula CM, et al. (2004) Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1α,25(OH) 2-vitamin D3 signaling Proceedings of the National Academy of Sciences of the United States of America. 101: 12876-12881 |
| Olivera CJ, Bula CM, Bishop JE, et al. (2004) Characterization of five 19-nor-analogs of 1alpha,25(OH)2-Vitamin D3 with 20-cyclopropyl-modified side-chains: implications for ligand binding and calcemic properties. The Journal of Steroid Biochemistry and Molecular Biology. 89: 99-106 |